EnZeta Immunotherapies, Inc.
through Mar 6, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Feb 20, 2025 · D | Mar 6, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $1,000,000 | $2,370,000 | $1,370,000 |
| Reported amount sold | $200,000 | $840,000 | $640,000 |
| Reported investor count | — | — | — |
| Reported minimum investment | $50,000 | $0 | $-50,000 |
Earlier SEC source: 0001994145-25-000001 · Later SEC source: 0001994145-26-000001
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $2,370,000
- Reported amount sold
- $840,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Contact info
Log in to look up an email or website for this issuer.
Form D filings (2)
-
0001994145-26-000001D/A · Mar 6, 2026 · BiotechnologyOffering: $2,370,000Sold: $840,000
-
0001994145-25-000001D · Feb 20, 2025 · BiotechnologyOffering: $1,000,000Sold: $200,000